Fundraising FoxAction Potential Venture Capital Ltd.
Venture capitalScotts Valley · Seed–Late Stage · 3 people tracked
Find your way into Action Potential Venture Capital Ltd.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Dune Thorne to introduce you to Juan-Pablo Mas
You →Dune · together at USA Lacrosse →Juan-Pablo
Ask Jamie Chen to introduce you to Imran Eba
You →Jamie · together at Alpheus Medical →Imran
Ask Sam Okafor to introduce you to Suraj Mudichintala
You →Sam · together at Arboretum Ventures →Suraj
Sign up to find every way you can get introduced to Action Potential Venture Capital Ltd.
- Your email: who you already know at Action Potential Venture Capital Ltd., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Action Potential Venture Capital Ltd. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Action Potential Venture Capital is a venture firm investing in healthcare and medical technology companies.
Source: firm website, verified Oct 2, 2026.
Team · 3 people
from public directoriesWhat they invest in
from 9 of 11 portfolio companiesHealthtech ×9Medical Devices ×8Biotech ×5Deep Tech ×3AI & Machine Learning ×1Digital Health ×1
HQs:United States×8
Investments · 11 tracked
founders shown can be your intro pathBy year:2025 · 42024 · 12019 · 22018 · 29 dated
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)Kevin Hykes(President, Chief Executive Officer & Director)in
Co-investorsABS VenturesNew Enterprise Associates (NEA)Treo Ventures, LlcWindham Capital PartnersYsios CapitalHatteras Venture Partners+1 more
Alpheus is a clinical-stage biotechnology company developing Porphyrin Metabolite Activation (PoMA™), a drug-led oncology approach designed to treat glioblastoma using proprietary low-intensity ultrasound to activate tumor-localized porphyrin metabolites.
BiotechHealthtechMedical DevicesChanhassen, US
Jeremy Ling(Executive Officer)inSteve Weiner(Executive Officer)Vijay Agarwal(Founder, President and CEO)inWilliam Davis(Executive Officer, Director)
BoardKlaus Veitinger(Director)inImran Eba(Executive Officer)in
Board seatJuan-Pablo Mas· per SEC Form D
Co-investorsOrbiMedHealthQuest CapitalSamsara BioCapitalSV Health InvestorsBrightEdge
Axon Therapies develops the SAVM procedure, an implant-free catheter-based ablation therapy that targets the right greater splanchnic nerve to reduce overactive sympathetic nerve activity in patients with heart failure with preserved ejection fraction (HFpEF).
HealthtechMedical DevicesNew York, US
Howard R. Levin(Executive Officer, Director)Mark Gelfand(Executive Officer)
BoardPaul LaViolette(Director)in
Board seatImran Eba· per SEC Form D · $15M raise · filed Feb 2019
Co-investorsStar51 CapitalDeerfield Management CompanyEarlybird Venture CapitalSV Health Investors
Exo is a company backed by leading venture capital and corporate investors focused on innovative technologies, with particular emphasis on healthcare, bioelectronic medicines, materials science, and deep technology solutions.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Yusuf Haque(Founder)in
Board seatJuan-Pablo Mas· per SEC Form D · $10M raise · filed May 2025
Co-investorsBold Capital PartnersCreative VenturesPage One VenturesTDK VenturesIntel CapitalOSF Ventures+5 more
.jpeg){kind=logo}
Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.
BiotechHealthtechMedical DevicesSan Jose, US
Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)inDave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)in
Board seatImran Eba· per SEC Form D
Co-investorsAlumni VenturesCerity Partners VenturesForeground CapitalPortfoliaTreo Ventures, LlcWindham Capital Partners+2 more
Saluda Medical develops the Evoke spinal cord stimulation (SCS) system, which records the spinal cord's physiologic response to stimulation using Evoked Compound Action Potentials (ECAPs).
Deep TechHealthtechMedical DevicesBloomington, US
Greg Plamondon(Executive Officer)inKristin Caplice(Executive Officer)inBarry Regan(Executive Officer, Director)inJames Schuermann(Director, Executive Officer)Geoffrey Kinghorn(Director)
Board seatJuan-Pablo Mas· per SEC Form D
Co-investorsWellington ManagementFidelity InvestmentsREDMILET. Rowe Price
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.
BiotechHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)inKevin Tracey(Founder)
Board seatJuan-Pablo Mas· per SEC Form D
Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersAsahi Kasei Corporate Venture CapitalCatalio Capital Management, LP+8 more
Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor.
Deep TechDigital HealthHealthtechMedical DevicesSilicon Valley, US
Kate Rosenbluth, PhD(President & Chief Innovation Officer)Kate Rosenbluth(Founder)inDeanna Harshbarger(Founder)in
Co-investorsAlumni VenturesAscension VenturesGlobal BrainGV (Google Ventures)Lightstone VenturesLux Capital+5 more
Co-investorsCWRU Technology VenturesShangBay Capital LLC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CALA HEALTH, INC.Gradient Denervation Technologies
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsCVRxNASDAQ: CVRX
Portfolio news
latest coverage across their companiesAlpheus Medical · alpheusmedical.com · Dec 9, 2025
Saluda Medical · prnewswire.com · Dec 9, 2025
Axon Therapies · prnewswire.com · Sep 25, 2025
Frequently asked questions
- How many investments has Action Potential Venture Capital Ltd. made?
- Action Potential Venture Capital Ltd. has 11 tracked investments, 1 of which have exited, including 5 dated in the last 24 months.
- What stage does Action Potential Venture Capital Ltd. invest at?
- Action Potential Venture Capital Ltd. invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Action Potential Venture Capital Ltd. focus on?
- Action Potential Venture Capital Ltd. focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Action Potential Venture Capital Ltd. located?
- Action Potential Venture Capital Ltd. is headquartered in Scotts Valley, US.
Co-investors · 8
ShangBay Capital is a venture capital firm that invests in founders building disruptive companies addressing high, unmet clinical needs with novel ideas.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Morgenthaler is a venture capital and private equity firm that has focused on building valuable companies for over 40 years.
Ysios Capital is a life sciences venture investor that finances innovative biotech companies developing novel therapies for high unmet medical needs, primarily across Europe and the United States.
Energy Impact Partners is an investment firm that connects entrepreneurs with major corporate partners to help drive the transformation of the global economy toward a more sustainable future.
Sandbox Industries is an investment firm that fosters innovation in the healthcare and insurance industries, partnering with corporate strategic investors as limited partners alongside financial investors and portfolio companies.
Cofounders Capital is a North Carolina-based venture firm that leads seed-stage investments in B2B software companies across the southeastern United States.
Firms observed investing alongside Action Potential Venture Capital Ltd., from public investor directories. Shared companies are the overlap with Action Potential Venture Capital Ltd.'s recorded portfolio.
Similar investors
EQT Life Sciences (formerly LSP) is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally.
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.
Vivo Capital is a global healthcare-focused investment firm operating a multi-strategy platform spanning venture capital, private equity, and public equity. It aims to expand healthcare access and drive innovation through its 'Ecosystem Strategy.'
The Blue Venture Fund is a partnership among participating Blue Cross Blue Shield companies, the BCBS Association, and Sandbox Industries that invests in healthcare technology, healthcare services, and clinical sciences companies. It aims to reduce costs and improve health outcomes for Blue Plan members.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.